SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-013113
Filing Date
2021-02-05
Accepted
2021-02-05 17:27:26
Documents
16
Period of Report
2021-02-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm213890d5_8k.htm   iXBRL 8-K 32552
2 EXHIBIT 1.1 tm213890d5_ex1-1.htm EX-1.1 201125
3 EXHIBIT 5.1 tm213890d5_ex5-1.htm EX-5.1 14095
7 GRAPHIC image_002.jpg GRAPHIC 3418
8 GRAPHIC image_003.jpg GRAPHIC 2053
  Complete submission text file 0001104659-21-013113.txt   482792

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rytm-20210204.xsd EX-101.SCH 3187
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rytm-20210204_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rytm-20210204_pre.xml EX-101.PRE 22711
9 EXTRACTED XBRL INSTANCE DOCUMENT tm213890d5_8k_htm.xml XML 3618
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 21597443
SIC: 2834 Pharmaceutical Preparations